Category Archives: Press Release

Distek, Inc. Awarded U.S. Patent for Multi-Motion Assembly Design

Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry, as well as an experienced provider of validation and qualification services, has been awarded U.S. Patent 9,333,469 for their multi-motion assembly design.

Distek’s patented, multi-motion assembly design, also known as D-Drive, allows for one assembly mechanism to provide both linear and rotational motion. This D-Drive technology, found on the symphony 7100 “Bathless” Dissolution Instrument, can raise and lower the shafts at various speeds as well as control and monitor the individual stirring speed in each dissolution vessel.

“Approval of this patent provides needed protection for a technically advance mechanical concept that is a core element of the innovation found in our symphony 7100 platform,” says Jeff Brinker, President, Distek, Inc. “We are excited to have been awarded this patent as this feature has proven to be of great value to our customers.”

To learn more about Distek, Inc., its products and services, contact Distek’s Corporate Office at +1 732 422 7585, by email at info@distekinc.com or visit http://www.distekinc.com.

ABOUT DISTEK, INC.

Distek, Inc., headquartered in North Brunswick, NJ, offers a robust product portfolio including water bath and bathless dissolution, dissolution media heating, degassing, dispensing and disposal, in-situ fiber optic UV, bathless tablet disintegration, content uniformity, digital video monitoring, programmable automated sampling and now a single-use bioreactor system for mammalian cell culture applications.

Leave a comment

Filed under Bathless, Press Release, Symphony 7100

Distek, Inc. Releases BIOne Single-Use Bioreactor System

 

North Brunswick, NJ – From the company that has brought you 40 years of excellence in laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne (pronounced “BIO One”) Single-Use Bioreactor System.

Distek, Inc. has developed a benchtop scale single-use bioreactor (SUB) system for mammalian cell growth and recombinant protein production. The pre-sterilized BIOne system is engineered with a disposable headplate welded to a tri-layer liner that can be easily inserted into a non-sterile bioreactor glass vessel, converting it to a sterile, disposable SUB within a matter of seconds with minimal investment. All materials are USP Class VI, animal derivative free and utilized in existing single-use products.BIOne - In & Out Vessel and Stand (With Callouts)

“Our expansion into the biotech arena marks another major milestone in Distek’s longstanding company history. As the bioreactor market continues shifting to single use technologies, our BIOne product line will offer an innovative approach to greatly assist our customers in the transition from autoclavable reactors,” says Jeff Brinker, President of Distek.

The “patent pending” BIOne SUB liner will mold to and mimic your existing glass system allowing you to continue using your existing cabinet, probes, motor, heating jacket and recipes. Since the liner is nearly identical to the existing glass vessel geometry, there is no need to change or modify your process.

The Distek BIOne system significantly reduces turnaround time by allowing users to seamlessly transition to a disposable platform while utilizing their existing equipment, without compromising the scalability of their current process.

“This is a very exciting product launch for us on many levels. Not only are we expanding our business into a new market space but we are immediately establishing Distek as an innovator just as we have been doing for over 40 years in small molecule dissolution testing,” says Jeff Seely, Vice President of Sales & Business Development, Distek, Inc.

To learn more about the BIOne Single-Use Bioreactor System, contact Distek’s Corporate Office at +1 732 422 7585, by email at bione@distekinc.com or visit http://www.distekinc.com.

Leave a comment

Filed under BIOne, Bioreactors, Distek, Press Release, Single-Use

Distek, Inc. Celebrates 40 Years in Business

North Brunswick, NJ – Distek, Inc., a leading manufacturer of pharmaceutical laboratory testing instruments, accessories and validation services, is proud to celebrate 40 years in business.Distek 40th Anniversary Logo

Founded in 1976 by Mr. Gerald Brinker, Distek has grown to offer innovation and support to companies worldwide. Like Disney, Apple, Google & Amazon, Distek, Inc. is a real life garage startup success story.

Born in Montreal, Quebec in 1940, Mr. Brinker received a B.S. in Chemical Engineering from McGill University in 1962. From 1969-1972 Mr. Brinker was a sales engineer in New York City for Beckman Instruments, responsible for sales and technical support to a wide range of medical institutions.

In 1972, Brinker Instruments, a manufacturers’ representative firm for analytical instrumentation, was formed. As the sole proprietor, Mr. Brinker was responsible for launching new products for many laboratory instrument manufactures. As the success of Brinker Instruments grew and the eagerness of Mr. Brinker to do more was encouraged by his wife Pearl; Distek was created and later incorporated on June 22, 1976.

Over the next four decades Distek’s business expanded to provide instruments for other tests performed in pharmaceutical laboratories including; in-situ fiber optic dissolution, bathless tablet disintegration testing, content uniformity, programmable automated sampling and more. In 1980, Gerald’s wife, Pearl, joined Distek and since then, the Company has grown significantly, with the majority of employees located at its facility in North Brunswick, NJ.

Distek’s core market includes brand name and generic pharmaceutical drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies, and universities. To ensure consistent quality and to meet the international standards of our world market, Distek has been ISO certified since 2002.

As a leader in the industry, Distek has an excellent reputation for innovation, product reliability, and customer support. It holds numerous patents for its instrumentation and accessories.

“It is our belief that quality, innovation and support are essential to our current and future growth and continual improvement is crucial to ongoing success,” states Mr. Brinker.

“Much of our success is dependent upon Distek’s employees’ dedication to providing products and services of the finest quality,” includes Mr. Brinker.

In early 2012, Mr. Brinker became the Chairman of the Company, leaving the day-to-day responsibilities of running the business to his son, Jeff Brinker. In addition to his more strategic role in growing Distek, Mr. Brinker is actively involved in new product development and product redesign.

“Reaching our 40th year anniversary is truly an exceptional accomplishment and a testament to our loyal employees and supportive customer base. We recognize that our customers require highly innovative and intuitive instruments coupled with strong service and support to meet their demanding regulatory compliance efforts. We strive each day to meet and exceed our customer’s needs,” says Jeff Brinker, President of Distek.

In summary, Distek is a growing business that relies upon technological innovations, strong marketing efforts, highly skilled and trained customer support, and dedicated employees for its future. For technological advancements that offer reliable and consistent performance, the pharmaceutical industry trusts Distek.

To learn more about Distek, Inc., its products and services, contact Distek’s Corporate Office at +1 732 422 7585, by email at info@distekinc.com or visit http://www.distekinc.com.

ABOUT DISTEK, INC.

Distek, Inc., headquartered in North Brunswick, NJ, is a leading manufacturer of pharmaceutical laboratory test equipment, specializing in dissolution products and services. Distek also provides solutions for UV fiber optics, media preparation, disintegration, content uniformity, and validation services.

Leave a comment

Filed under 40th Anniversary, Dissolution, Distek, Press Release

Distek, Inc. Awarded U.S. Patent for Modularity Design and Position Software Control

North Brunswick, NJ – Distek, Inc., an industry leader in pharmaceutical laboratory testing instruments, accessories and validation services, has been awarded U.S. Patent 8,903,673 for their modularity design and the individual position software control.

Distek’s patented, self-contained, modularity design is configurable for up to 8 positions when in use on the symphony 7100 “Bathless” Dissolution Instrument and 6 positions when in use on the sensIR 3200 “Bathless” Disintegrator.  This modularity design allows users unprecedented ease and scalability.

“Distek is excited to have been awarded this patent which exemplifies our commitment to providing technically innovative products offering valuable feature benefits to our customer base,” says Jeff Brinker, President, Distek, Inc.  “This patent in particular allows our customers a great deal of flexibility in the symphony 7100 and sensIR 3200 platforms in its modularity both mechanically as well as in the user interface design.”

For additional information contact Distek’s Corporate Office at +1 732 422 7585, by email at info@distekinc.com or visit www.distekinc.com.

ABOUT DISTEK, INC.

Distek, Inc., headquartered in North Brunswick, NJ, is a leading manufacturer of pharmaceutical laboratory test equipment, specializing in dissolution products and services.  Distek also provides solutions for UV fiber optics, media preparation, physical testing, disintegration, and validation services.

Leave a comment

Filed under Press Release, sensIR 3200, Symphony 7100